Alexander Martin-Odoom1, Theophilus Adiku2, Elena Delgado3, Margaret Lartey4, William K Ampofo5. 1. Department of Medical Laboratory Sciences, School of Biomedical & Allied Health Sciences, College of Health Sciences, University of Ghana. 2. Department of Medical Microbiology, School of Biomedical and Allied Health Sciences, College of Health Sciences, University of Ghana. 3. Centro Nacional de Microbiología, Department, Patogenia Viral/Uni of Biology and Variability of HIV, Instituto de Salud Carlos III, Ctra. de Majadahonda a Pozuelo, Km. 228220 Majadahonda (Madrid) Spain. 4. Department of Medicine, School of Medicine and Dentistry, College of Health Sciences, University of Ghana. 5. Department of Virology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Ghana.
Abstract
BACKGROUND: Access to antiretroviral therapy in Ghana has been scaled up across the country over the last decade. This study sought to determine the occurrence of transmitted HIV-1 drug resistance in pregnant HIV-1 positive women yet to initiate antiretroviral therapy at selected HIV Care Centres in Ghana. METHODS: Plasma specimens from twenty-six (26) HIV seropositive pregnant women who were less than 28weeks pregnant with their first pregnancy and ART naïve were collected from selected HIV care centres in three (3) regions in Ghana. Genotypic testing was done for the reverse transcriptase gene and the sequences generated were analyzed for HIV-1 drug resistance mutations using the Stanford University HIV Drug Resistance Database. RESULTS: Resistance mutations associated with the reverse transcriptase gene were detected in 4 (15.4%) of the participants. At least one major drug resistance mutation in the reverse transcriptase gene was found in 3 (11.5%) of the women. CONCLUSION: The detection of transmitted HIV-1 drug resistance in this drug-naïve group in two regional HIV care sites is an indication of the need for renewed action in monitoring the emergence of transmitted HIV-1 drug resistance in Ghana. FUNDING: None declared.
BACKGROUND: Access to antiretroviral therapy in Ghana has been scaled up across the country over the last decade. This study sought to determine the occurrence of transmitted HIV-1 drug resistance in pregnant HIV-1 positive women yet to initiate antiretroviral therapy at selected HIV Care Centres in Ghana. METHODS: Plasma specimens from twenty-six (26) HIV seropositive pregnant women who were less than 28weeks pregnant with their first pregnancy and ART naïve were collected from selected HIV care centres in three (3) regions in Ghana. Genotypic testing was done for the reverse transcriptase gene and the sequences generated were analyzed for HIV-1 drug resistance mutations using the Stanford University HIV Drug Resistance Database. RESULTS: Resistance mutations associated with the reverse transcriptase gene were detected in 4 (15.4%) of the participants. At least one major drug resistance mutation in the reverse transcriptase gene was found in 3 (11.5%) of the women. CONCLUSION: The detection of transmitted HIV-1 drug resistance in this drug-naïve group in two regional HIV care sites is an indication of the need for renewed action in monitoring the emergence of transmitted HIV-1 drug resistance in Ghana. FUNDING: None declared.
Entities:
Keywords:
antiretroviral therapy; drug resistance; emergence; mutations
Authors: Matt A Price; Carole L Wallis; Shabir Lakhi; Etienne Karita; Anatoli Kamali; Omu Anzala; Eduard J Sanders; Linda-Gail Bekker; Rogers Twesigye; Eric Hunter; Pontiano Kaleebu; Kayitesi Kayitenkore; Susan Allen; Eugene Ruzagira; Mary Mwangome; Gaudensia Mutua; Pauli N Amornkul; Gwynn Stevens; Sergei L K Pond; Malinda Schaefer; Mary A Papathanasopoulos; Wendy Stevens; Jill Gilmour Journal: AIDS Res Hum Retroviruses Date: 2010-11-23 Impact factor: 2.205
Authors: E Y Bonney; N A Addo; N A A Ntim; F Addo-Yobo; P Bondzie; K-E Aryee; J Barnor; J Brandful; V Bekoe; S-A Ohene; W Ampofo Journal: Ghana Med J Date: 2013-06
Authors: Victoria A Johnson; Vincent Calvez; Huldrych F Gunthard; Roger Paredes; Deenan Pillay; Robert W Shafer; Annemarie M Wensing; Douglas D Richman Journal: Top Antivir Med Date: 2013 Feb-Mar
Authors: M L Villahermosa; M Thomson; E Vázquez de Parga; M T Cuevas; G Contreras; L Pérez-Alvarez; E Delgado; N Manjón; L Medrano; R Nájera Journal: J Hum Virol Date: 2000 Jan-Feb
Authors: Nicholas I Nii-Trebi; Shiro Ibe; Jacob S Barnor; Koichi Ishikawa; James A M Brandful; Sampson B Ofori; Shoji Yamaoka; William K Ampofo; Wataru Sugiura Journal: PLoS One Date: 2013-08-19 Impact factor: 3.240
Authors: Christopher Z Abana; Kwamena W C Sagoe; Evelyn Y Bonney; Edward K Maina; Ishmael D Aziati; Esinam Agbosu; Gifty Mawuli; Linda M Styer; Koichi Ishikawa; James A M Brandful; William K Ampofo Journal: Medicine (Baltimore) Date: 2019-02 Impact factor: 1.817